These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9819316)

  • 1. Inhaled beta2-agonists and airway responses to allergen.
    Cockcroft DW
    J Allergy Clin Immunol; 1998 Nov; 102(5):S96-9. PubMed ID: 9819316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
    Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
    Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
    Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.
    O'Connor BJ; Aikman SL; Barnes PJ
    N Engl J Med; 1992 Oct; 327(17):1204-8. PubMed ID: 1357551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regular inhaled salbutamol and airway responsiveness to allergen.
    Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
    Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
    Verberne AA; Hop WC; Bos AB; Kerrebijn KF
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):127-34. PubMed ID: 8093705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against allergen-induced asthma by salmeterol.
    Twentyman OP; Finnerty JP; Harris A; Palmer J; Holgate ST
    Lancet; 1990 Dec; 336(8727):1338-42. PubMed ID: 1978163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma.
    O'Connor BJ; Fuller RW; Barnes PJ
    Am J Respir Crit Care Med; 1994 Aug; 150(2):381-7. PubMed ID: 8049819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to the protective effect of salmeterol on allergen challenge.
    Giannini D; Carletti A; Dente FL; Bacci E; Di Franco A; Vagaggini B; Paggiaro PL
    Chest; 1996 Dec; 110(6):1452-7. PubMed ID: 8989060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to the protective effect of salmeterol in mild untreated asthmatics.
    Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Taccola M; Tonelli M; Zingoni M; Paggiaro P
    Pulm Pharmacol Ther; 2003; 16(6):355-60. PubMed ID: 14580927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma.
    Roberts JA; Bradding P; Britten KM; Walls AF; Wilson S; Gratziou C; Holgate ST; Howarth PH
    Eur Respir J; 1999 Aug; 14(2):275-82. PubMed ID: 10515401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.